Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 342,847 shares, a growth of 286.3% from the September 30th total of 88,752 shares. Approximately 14.9% of the shares of the company are sold short. Based on an average trading volume of 5,307,777 shares, the short-interest ratio is presently 0.1 days.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Arcadia Biosciences in a research note on Tuesday, September 22nd. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Arcadia Biosciences currently has a consensus rating of “Sell”.
Check Out Our Latest Stock Report on Arcadia Biosciences
Arcadia Biosciences Price Performance
RKDA traded down $0.02 during trading on Friday, reaching $0.15. 491,987 shares of the company’s stock were exchanged, compared to its average volume of 1,530,803. The stock has a market capitalization of $357,495.60, a P/E ratio of -0.03 and a beta of 0.56. Arcadia Biosciences has a 1 year low of $0.11 and a 1 year high of $4.18. The company’s fifty day simple moving average is $0.34 and its 200-day simple moving average is $1.03.
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last announced its earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%. The business had revenue of $1.44 million for the quarter, compared to analyst estimates of $1.90 million.
About Arcadia Biosciences
Arcadia Biosciences, Inc is an agricultural biotechnology company focused on developing and commercializing food ingredients and crop-based products intended to support health and wellness. The company applies plant science and breeding technologies to develop crops with enhanced nutritional characteristics and products designed for consumer and food-industry applications.
Its product portfolio has included GoodWheat, a wheat variety developed with increased dietary fiber and other nutritional attributes, as well as GoodHemp, a line of hemp-based food products and ingredients.
See Also
- Five stocks we like better than Arcadia Biosciences
- Silicon Shock: Intel’s 25% Valuation Reset
- Advanced Micro Devices’ Meta Platforms Partnership Goes Beyond a $1 Billion Investment
- Chipotle’s $32 Floor: Is a Major Stock Rebound Coming?
- SaaS-Pocalypse II: Is ServiceNow’s Sell-Off Another Buying Opportunity?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
